Bank of New York Mellon’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-97,814
| Closed | -$611K | – | 4473 |
|
|
2023
Q1 | $611K | Sell |
97,814
-1,197
| -1% | -$7.48K | ﹤0.01% | 3381 |
|
|
2022
Q4 | $604K | Buy |
99,011
+1,690
| +2% | +$10.3K | ﹤0.01% | 3457 |
|
|
2022
Q3 | $1.16M | Buy |
97,321
+8,792
| +10% | +$105K | ﹤0.01% | 3128 |
|
|
2022
Q2 | $1.12M | Sell |
88,529
-4,492
| -5% | -$56.7K | ﹤0.01% | 3162 |
|
|
2022
Q1 | $1.05M | Sell |
93,021
-1,317
| -1% | -$14.8K | ﹤0.01% | 3282 |
|
|
2021
Q4 | $1.67M | Buy |
94,338
+27,348
| +41% | +$485K | ﹤0.01% | 3097 |
|
|
2021
Q3 | $1.54M | Buy |
66,990
+26,267
| +65% | +$605K | ﹤0.01% | 3148 |
|
|
2021
Q2 | $948K | Buy |
40,723
+4,957
| +14% | +$115K | ﹤0.01% | 3447 |
|
|
2021
Q1 | $1.12M | Buy |
+35,766
| New | +$1.12M | ﹤0.01% | 3267 |
|